Switchpoint Ventures, which helps companies build and operationalize Artificial Intelligence solutions, is teaming up with Raiven Health, a provider of prescriptive analytics solutions for behavioral health organizations, to further the capabilities of the Raiven platform and its ability to deliver assisted decision making enhanced by Artificial Intelligence.
For organizations engaged in risk-based contracts such as Accountable Care Organizations, Raiven focuses on care beyond the clinic and through case management to help providers navigate patient treatment or intervention. As a result of this partnership, Damian Mingle, chief data scientist for Switchpoint, will work with Raiven Healthcare, in an advisory capacity, to help accelerate the development of its AI platform. Mingle previously held the position of chief data scientist at data science company WPC Healthcare, who along with Ray Guzman, chief executive officer and Nolan Rhem, chief operating officer, facilitated its acquisition by Intermedix.
Mingle will participate in a panel called “Tools of Change” with other industry leaders on Oct. 11 at 9:35 AM at The Cohen Veterans Care Summit in Washington DC. Cohen Veterans Bioscience and Cohen Veterans Network, funded by billionaire Steve Cohen, host the summit, which seeks to advance Post Traumatic Stress (PTS) and Traumatic Brain Injury (TBI) care.
Learn more about the summit at https://www.cohencaresummit.org
“First-hand I have seen the impact that artificial intelligence can have when embedded into a proper workflow within organizations. The AI solutions that Raiven has developed to date are marvelous and truly cutting-edge. Raiven is offering its clients a way to optimize decision-making within a behavioral health setting that is often inefficient, costly, and latent with suboptimal outcomes. Switchpoint is excited to be arm-in-arm with an organization looking to revolutionize the industry,” said Mingle.
“We know clinicians can benefit from our AI tool to help make the best treatment choices for their patients,” says Dr. Jim Stefansic, president and chief executive officer for Raiven. “Partnering with Switchpoint Ventures to further refine and enhance our platform is good news for all those who want to achieve the best possible outcomes for their patients at the lowest cost.”
About Switchpoint Ventures
For more than five years, the founders of Switchpoint Ventures have been working to create artificial intelligence solutions that make a difference in the lives of people. The company’s name was inspired by switchpoint analysis, a powerful analytic tool that determines where a change has occurred that might be overlooked through traditional data techniques. Switchpoint Ventures is an innovation enabler making AI investments in organizations that seek transformation through machine learning. Through its partnerships and portfolio companies, Switchpoint delivers the strategy, capital, operational expertise, and machine learning capabilities to identify ways to monetize, manage, and measure information as an asset creating competitive advantage. Switchpoint helps companies connect to AI capability and investors connect to AI opportunity. Learn more at http://www.switchpointventures.com.
